FindTrial
Sign In

Seprafilm

DEVICE5 trials

Sponsors

Nihon University, Stan Stawicki, Weill Medical College of Cornell University, South East Area Health Education Center, Wilmington, NC, Gachon University Gil Medical Center

Conditions

Abdominal AdhesionsGastric CancerIntrauterine AdhesionsOpen AbdomenPatient Under Going Colorectal and Stomach Cancer SurgeryTissue AdhesionsTraumaWounds and Injury

Phase 3

Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction
CompletedNCT00529412
Nihon UniversityGastric Cancer
Start: 2003-08-31End: 2007-03-31Updated: 2007-09-14
Randomized Control Trial on Seprafilm and Guardix in Preventing Ileus
CompletedNCT02168426
Gachon University Gil Medical CenterPatient Under Going Colorectal and Stomach Cancer Surgery
Start: 2013-08-31End: 2015-02-28Updated: 2015-09-01

Phase 4

Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy
TerminatedNCT01632202
Weill Medical College of Cornell UniversityIntrauterine Adhesions
Start: 2012-05-31End: 2014-01-31Updated: 2020-12-03

Unknown Phase

Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
CompletedNCT01594385
Stan StawickiAbdominal Adhesions, Open Abdomen, Trauma +1
Start: 2010-04-30End: 2013-12-31Updated: 2017-11-20
A Trial to Reduce Adhesions Following a Primary Cesarean Section
TerminatedNCT01819467
South East Area Health Education Center, Wilmington, NCTissue Adhesions
Start: 2014-06-30End: 2016-09-30Updated: 2023-08-16

Related Papers

Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial.
2008-05-0148 citations